Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Net Margin (2018 - 2026)

Insmed's Net Margin history spans 12 years, with the latest figure at 53.46% for Q1 2026.

  • Quarterly Net Margin rose 22296.0% to 53.46% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 144.44% through Mar 2026, up 12149.0% year-over-year, with the annual reading at 210.54% for FY2025, 4070.0% up from the prior year.
  • Net Margin came in at 53.46% for Q1 2026, up from 124.5% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 53.46% in Q1 2026 to a low of 332.75% in Q2 2024.
  • The 5-year median for Net Margin is 225.53% (2024), against an average of 222.94%.
  • Year-over-year, Net Margin tumbled -17034bps in 2023 and then skyrocketed 22296bps in 2026.
  • Insmed's Net Margin stood at 270.02% in 2022, then rose by 18bps to 222.31% in 2023, then dropped by -1bps to 225.53% in 2024, then soared by 45bps to 124.5% in 2025, then soared by 57bps to 53.46% in 2026.
  • Per Business Quant, the three most recent readings for INSM's Net Margin are 53.46% (Q1 2026), 124.5% (Q4 2025), and 259.95% (Q3 2025).